As shown in Figure 2, SEC23A expression in advanced bladder tumor samples was significantly higher than that in early stage tumor samples (T1+2 vs T3+4, N0 vs N+, Stage I + II vs Stage III + IV; p < 0.05; Figure 2A). The gene discussed is SEC23A; the disease is urinary bladder neoplasm.